(FG) F&G Annuities & Life - Ratings and Ratios

F&G Annuities & Life Inc. is a leading provider of annuity and life insurance products in the United States, operating under the umbrella of Fidelity National Financial, Inc. The company offers a diverse range of products, including fixed indexed annuities, registered index-linked annuities, multi-year guarantee annuities, immediate annuities, indexed universal life insurance, pension risk transfer solutions, and institutional funding agreements. These products cater to the needs of retail annuity and life customers, as well as institutional clients, through distribution channels such as independent agents, banks, and broker-dealers.

With a rich history dating back to 1959, F&G Annuities & Life Inc. has established itself as a reputable player in the life and health insurance sub-industry. Headquartered in Des Moines, Iowa, the company leverages its expertise to provide tailored solutions for its clients. The companys product portfolio is designed to address the complex needs of its customers, providing a range of options for retirement planning, risk management, and wealth accumulation.

Analyzing the companys , we observe that the stock has experienced a decline in value over the past year, with a 52-week high of $48.27 and a low of $30.17. The current price of $33.24 is near the 52-week low, indicating a potential buying opportunity. The SMA20 and SMA50 are converging, suggesting a potential trend reversal. Furthermore, the ATR indicates a moderate level of volatility, with a 3.05% daily price movement.

From a fundamental perspective, F&G Annuities & Life Inc. has a market capitalization of $4.35 billion and a P/E ratio of 8.50, indicating a relatively undervalued stock. The forward P/E ratio is even lower, at 4.86, suggesting that the market expects earnings to grow in the future. The RoE of 12.23% indicates that the company is generating strong returns on equity.

Using a combination of and , we can forecast a potential price target for F&G Annuities & Life Inc. Based on the converging SMA20 and SMA50, and the relatively low P/E ratio, we expect the stock price to appreciate in the coming months. Assuming a continued decline in volatility and a stable macroeconomic environment, we forecast a price target of $40.00 within the next 6-12 months, representing a potential upside of 20% from current levels.